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ABSTRACT
Effects of Methylene Chloride on Immune Function in Mice and
the

Jn Yi1rll. Effect of Methylene Chloride
in Immunologic Assays

by
Man-Ping Wang, Master of Science
Utah State University, 1989
Major Professor: Dr. Reed P. Warren
Department : Biology
A number of toxicities associated with methylene chloride have been found in both
human subjects and mice. However, relatively few studies have probed immunotoxicities
of methylene chloride.

In order to

examine possible immunotoxicities

or

immunomodulating effects of methylene chloride, several tests of cellular immun e
function were performed using both human

in ll.iJ.rQ studies and a mouse model.

Body weights and specific organ weights of thymus , spleen , liver, and kidney
were normal in CD-1 mice given various concentrations of methylenechloride. However,
a significantly reduced mitogenic response to phytohemagglutinin (PHA} and reduced
interleukin-2 (IL-2} production was

found in these methylene-chloride -treated mice.

The findings in the mouse model provide additional evidence that immune suppression
may be associated with exposure to methylene chloride.
Splenic mononuclear cells isolated from CD-1 mice were incubated with variou s
concentrations of methylene chloride

in Yi.J.[Q. and investigated for blastogenic response

to mitogen PHA and IL·2 production. The results show no significant difference between
methylene-chloride-treated cells and the cells treated with growth media.

ix
Peripheral blood mononuclear cells isolated from healthy donors were incubated
with variou ·; concentrations of methylene ch loride and tested for blastogenic activity,
natural killer (NK) cell activity, and IL-2 production . The findings showed that the NK
cell activity, the T-cell blastogenesis in response to PHA mitogen, and IL-2 production
activity were not affected.

(60 Pages)

CHAPTER I
INTRODUCTION
lmmunotoxicology is a study of the adverse effects on the immune system
resulting from the action of xenobiotics (i. e., chemicals. drugs. and biologica ls). which
have a potential for long-term exposure and are persistent in the environment. Many
studies have shown that exposure of rodents to classes of environmental chemicals at
doses that are not toxic induce immune alteration and change host resistance to infection
agents (e. g .• bacteria and viruses) and neoplastic cells (1 ).
human subjects to certain xenobiotics results in

Accidental exposure of

immunomodulation . For example,

exposu re of Michigan residents to dairy-farm products that were contaminated with
polybrominated biphenyls (PBB) (2) and exposure of Taiwanese and Japanese to rice oil
contaminated

with

polychlorinated

biphenyl

(PCB)

(3)

resulted

in

immune

abnormalities.
The interaction of environmental chemicals or drugs with lymphoid tissue may
alter immune function and result in six effects. which were reviewed by Dean et. at ( t ):
1. Immunosuppression: some chemicals,

drugs, and metals (4) are agents that can

suppress both cell-mediated immunity and humoral immunity. 2. Uncontrolled
proliferation: some chemicals or their metabolites can bind to the genetic materia:
(DNA) and lead to genetic alteration that may result in neoplastic development (5) . 3.
Decreased host surveillance against pathogens and neoplasm: an increased incidence of
infectious disease and neoplasia have been frequently associated with immunodeficiency
diseases and immunosuppressant therapy (6). Lymphocyte deficiency: deficiencies of the
T cells are mainly associated with severe viral infections. intracellular pathogens. and
fungi. Deficiencies

of E: cells are frequently associated with bacterial infections. 4.

Allergy: industrial workers are exposed to many environment chemicals capable of
inducing asthma. hypersensitivity. and contact dermatitis (7). 5. Autoimmunity: many
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drugs and metals may haptenate self-protein and result In autoimmune diseases (8).
Several mechanisms that may explain the induction of autoimmune disorders were
rev iewed by Theofilepoulos (9 ). Cross -reaction drugs with self-DNA or nucl ea r
antigens and interference with the immunoregulatory function of suppressor T cells
(10) are two possible mechanisms for autoimmune diseases. 6. Alteration of drug
metabolism : inhibition of hepatic drug metabolism is a common consequence of
pharmacological immunostimulating that so far has been reported with mos t
immunomodulation agents (11). As pharmacolog ical drugs are usually biotransformed in
the liver to less active and more soluble metabolites by hepatic enzymes (12), any
inhibi tion of hepatic enzymes, e.g., immuno-chemotherapeutic , is likely to cau se a
relative overdose and result in toxicity.
Halogenated hydrocarbons are industrially important agents us ed as solvents.
chemicals, intermediates, and consumer products. Many of them are liver and kidn ey
toxins in both animals and humans (13) . Several chlorinated hydrocarbons are known to
be carcinogenic. Vinyl chloride has been reported to be carcinogenic in man (14 ).
Chloroform, carbon tetrachloride, and other chlorinated hydrocarbons are carc inogens
(15) . Carbon tetrachloride induces liver and adrenal tumors in mice (16) and
neoplastic nodules in the liver of rats (16) . Chloroform is known to cau se
hepatocellular carcinomas in mice and kidney tumors in male rats (16). Recently , many
immunotoxicities

associated with chlorinated hydrocarbons have been studied in

experimental animals. (17). Alterations of various immune parameters have been noted
following aliphatic-hydrocarbon exposure in laboratory animals (18 , 19).
The present study investigated the effects of methylene chloride on th e imm une
systems of man and of mice. Three approaches were employed to investigate the effects of
methylene chloride on immune function . Peripheral blood mononuclear cells (PBMC )
were isolated from healthy donors and studied for NK cell activity, T-cell blastogen ic
activity, and IL-2 production. Splenic mononuclear cells were isolated from CD-1 mice
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and studied for T-cell blastogenic activity and IL-2 production activity as in the human

in .l'.i1rll. study. A murine model to study the effects of methylene chloride on immune
function was developed by giving mice short-term exposure to methylene chloride and
studying their lymphocytes for IL-2 production and blastog enic activity . The specific
objectives of the study were to determine if human PBMC exposed in...ld..lrQ. to methylene
chloride will have altered T-cell blastogenic responses, NK cell function, or IL-2
production; if murine splenic mononuclear cells exposed

in ld..lrQ. to methylene chloride

will have altered T-cell blastogenic responses or IL-2 production activity; and if mice
exposed

in...~

to methylene chloride will have altered T-cell blastogenic responses,

IL-2 production, or body and major organ (thymus, liver, spleen, and kidney) weights .
It is hoped that the results will aid in better understanding the interactions between

methylene chloride (a wide-spread environmental pollutant) and the immune system. ·
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CHAPTER II
REVIEW OF THE UTERATURE
pescriptjon of Methylene Chloride

Methylene chloride (dichloromethane} is a halogenated aliphatic hydrocarbon
that is produced by chlorinating either methane or methyl chloride, or by reduction of
chloroform or carbon tet:achloride (20}. The current major uses of methylene chloride
in the United States are in paint removers, aerosol sprays, solvent degreasers, and in
plastics processing (20}. Methylene chloride is also used in the textile industry as a
solvent for cell ulose triacetate in rayon yarn manufacture, in the production of PVC
{po lyvinyl chloride} fiber, as a low-temperature extractant (e. g. , edible fat. butter,
and cocoa}. in beer flavoring, and as a substitute for trichloroethylene for decaffeinating
coffee. The demand of methylene chloride has grown in the past decade in paint removers
and in solvent -degreasing operations, manufacturing of aerosol propellants, plastics.
and photographic film. It is estimated that about 70,000 U.S. employees are exposed to a
working environment containing methylene chloride in one year (20}.
Methylene chloride is a cheap , nonflammable, colorless , low-boiling point,
organic solvent with a boiling point and properties similar to chloroform and carbon
tetrachloride . It can enter the body by inhalation of vapors , absorption of liquid.
ingestion , skin and eye contact, or food and water contamination. Due to its high chemical
stability, methylene chloride has become distributed throughout the biosphere .
Recently, methylene chloride was recognized by the Environmental Protection Agency
(EPA} as a priority pollutant.

Toxjcitjes Assocjated wjth Methylene Chlorjde

Renal necrosis.

A case of nephrotoxicity was reported to occur after inhalation

of methylene chlorid~ and manifested as acute renal failure , myoglobinuri a,
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hypocomplementemia, and liver-enzyme elevations (21 ). Serum enzymes were also
elev ated, including

lactate dehydrogenase (LDH) and serum glutamate oxaloacetic

tra nsaminase (SGOT). ln ~ reased levels of creatine kinase and myoglobin in the urine also
occurred after acute rtinal failure (22) . With light microscopy. the cytoplasm of the
tubular cells appeared degenerated and contained cellular debris. Both the proximal and
distal tubules were affected. Under electron microscopy , the tubular cells were
extremely electron lucent and in disarray. In some cells , the plasma membrane was
greatly disrupted and devoid of cellular contents. The mitochondria were swollen and the
intercristae spaces widely separated (21 ).
Pulmonary injury.

A case of pulmonary edema and pleural effusion resulting

from methylene chloride inhalation was described by Buie et al. (23) . Two cases of
pulmonary parenchymal damage, one of which was fatal , were reported to have occurred
following methylene chloride intoxication (24) . Gerritsen and Buschmann (24) showed
that phosgen, a combustion product of methylene chloride, damage the lung parenchyma
and cause airway and alveolar edema (24). Methylene chloride forms hydrochloric acid
in the presence of warmth and moisture (25). Hydrochloric acid may also be the agent
responsible for the pulmonary parenchymal reaction (23) .
Central nervous system (CNS) damage.

Toxicity of methylene chloride on the

CNS was first described in 1936 (26) when Collier reported that workers in the paint
industry in England suffered from headache, sedation, and confusion. Effects on the CNS
are related to the anaesthetic properties of the solvent. Intermittent exposure of rats to
I

dichloromethane for two weeks causes neurochemical changes, including signs of
increased protein breakdown in the cerebrum (27).
In man , certain brain areas are especially vulnerable to methylene chloride
expos ure, for example, the anterior parts of the cerebral cortex and the vermis
posterior of the cerebellum (28) . Briving et al. (29) observed that long -term exposure
of Mongolian

gerbils (Meriones ungiculatus) to dichloromethane leads to decreases
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levels of glutamate, gamma-aminobutyric acid and phosphoethanolamine in the frontal
cerebral cortex, while glutamine and gamma-aminobutyric acid are elevated in the
posterior cerebellar vermis .
Some studies show that traumatic damage to a CNS tissu e frequently causes
hypertrophy or proliferation of astroglial cells

detected by immunohistochemical

methods using specific antibodies to astroglial marker proteins (30}. Rosengren et. al
(31} found increased concentrations of astroglial marker proteins

in the frontal

cerebral cortex and the sensory motor cerebral cortex, but DNA concentration was
signif icantly decreased in the hippocampus and in the cerebellar hemispheres after
exposure to methylene chloride .
Carbon monoxide toxicity.

Carbon monoxide toxicity is caused by elevated blood

levels of carboxyhemoglobin (COHb} (27}. The mechanism of carbon monoxide toxicity
is associated with carbon monoxide's high affinity for hemoglobin which is two hundred
times higher than that of oxygen, and its interference with the release of oxygen from
oxyhemoglobin present in the blood. Carbon monoxide poisoning can be a serious threat
to the central nervous system (CNS} and myocardium, which are most sensitive to
oxygen deprivation (32}. Carbon monoxide is a serious hazard to patients with coronary
artery disease since

only a slight elevation in carboxyhemoglobin concentration

necessitates greatly increased coronary blood flow to prevent ischemia (33}. Studies
found that methylene chloride is metabolized to carbon monoxide by human subjects
(34}, rats , and mice (35}. Exposure of the experimental rat and human subject to
[ 14C] methylene chloride (14cH2CI2} leads to the highest tissue uptakes of 14c in the
liver, kidney, and adrenal gland (34}. Alter exposure to CH2CI2 , the concentration of
blood carboxyhemoglobin is increased. Methylene chloride is released slowly from body
tissues, resulting in carbon monoxide remaining in circulation for a prolonged period.
The half-life of carboxyhemoglobin resulting from methylene chloride is much higher
lhan that caused by c~rbon monoxide inhalation. Hence, the carboxyhemoglobin
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concentration is higher after inhaling methylene chloride. Therefore, cardiovascular
compromise

and cerebral damage by inducing hypoxia (36) from elevated

carboxyhemoglobin may be the result of dichloromethane exposure.
Mutagenicity and carcinogenicity. The potential carcinogenicity of some

halogenated aliphatic hydrocarbons is related to their metabolic activation by the hepatic
microsomal monooxygenase system (37, 38) . Methylene chloride has been reported to
be highly mutagenic in some short-term tests using microorganisms , including
Salmonella typhimurium strains

TA

1535 (39) and TA 100 (40) . In these assays

methylene chloride can cause base-pairing substitutions. Methylene chloride also has
been shown to be mutagenic in the Salmonella typhimurium

TA98 (39 , 40),

Saccharomyces cerevisial (38), and baby hamster kidney (BHK21) cell transformation

assays. Thilagar and Kumaroo

(41) reported that methylene chloride can induce the

chromosome frameshift mutations in chinese hamster ovary cells (CHO). Also, Fishbein
(20) has found that methylene chloride can induce tumors when injected
immunosuppressed

into

mice . Burek et al. (42) reported a two-year inhalation study with

dichloromethane in rats and hamsters at different levels. In this study, rats of both sexes
exhibited an increased number of benign mammary tumors and an increased incidence of
salivary gland sarcomas in males. Methylene chloride also has been evaluated for its
ability to

induce micronucleated

marrow of

treated mice (43). A recent report from Andrew et al. (44) indicates that

polychromatic erythrocytes (MPEs) in the bone

methylene chloride is a liver and lung carcinogen in the mouse.
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Possjble Mechanjsm of Toxjcitles Assocjated wjth
Methylene Chlorjde Exoosure

Much work has been done to determine the metabolic pathways involved in
methylene chloride biotransformation to elucidate possible mechanisms of carbon
mono xide production and potentially reactive intermediates that may be involved in the
mutagenic effects. Both in~ and

in ri1rc.

studies have shown that dihalomethanes are

metaboli zed by two major pathways (45) : hepatic microsomal cytochrome P-450
dependent mixed function oxidase system, and glutathione S-trans!erase dependent
pathways in hepatic cytoso l. These

two pathways have been investigated in detail by

Anders et a!. (46).
The

cytochrome P-450 containing monooxygenase is localized in the smooth

endoplasmic reticulum , a complex

network of membranes that is continuous with the

outer nuclear membrane. When a cell Is homogenized, the smooth endoplasmic reticulum
disintegrates to form intracellular organelles known as microsomes.
In the oxidative pathway methylene chloride may be metabolized in the hepatic
microsomal fraction requiring both molecular oxygen and NADPH (45) . Formation of CO
from

methylene chloride is mediated by the microsomal cytochrome

P-450

monooxygenase system (47) . The proposed reaction mechanism lor the metabolism of
CH2CI2 to CO is shown below (7, 47) .

H

I

H
NADPH, [OJ

Cf-C-<:1

I

H

I

CI-C-CI
Cytochrome P-450

I

OH

-x-

CJ-C-H
u
0

9
( A):

(1)

-H+

--7

-x-

C=O

Bio. Nuc. (N, 0 , S)

(2)

RNuH

RNu - C-H
~
0

or

( 8) :

GSH
+
-H+
CI-C-H --;..G-S-C=O ~ G·S-C=O

I I

II

0

N:

GSH

I

H H

H

Nitrogen

0:

Oxygen

S:

Sulfur

RNu : Biological Nucleoph'les (1. e. DNA, RNA and proteins)
The

above reaction shows an initial oxygen insertion reaction to produce a

hydroxydichloromethane intermediate (H OCHCI2) which would be rearranged to produce
a formyl chloride intermediate .

The

formyl halide intermediate may be either

decomposed spontaneously to carbon monoxide or it can acylate tissue nucleophiles. Due
to lhe reaction, dichloromethane becomes covalently bound to both microsomal proteins
and lipids (46, 47) .
The glutathione S-transferase (GST) pathway produces C02 but no CO (45). The
proposed reaction mechanism is shown below:
H

I

Cytosol -H +

CI-C-H

I

H

NAD+
GS-CH2-0H

GSH

-X-

HCOOH
GS-C=O - - - 7 C02

I

H

l0
Reactive , potentially toxic intermediates are formed in both pathways (47) .
Either metabolic pathway can produce carbon dioxide, but only the cyt P-450 pathway
yields carbon monoxide.
Reyjew of the lmmpne System And Its Ftmctjons

Recently, immunologists have become concerned about the

immune system as a

target organ for toxicity (48). One possible reason for this is that toxic chemicals may
alter immunologic function and increase disease susceptibility (48). The main role of
immune system is to sustain host defense mechanism and to maintain homeostasis. The
immune system can be divided into two parts, central lymphoid organs and peripheral
lymphoid organs. The central lymphoid tissues include thymus and bone marrow (bursa
of labricius). The peripheral lymphoid tissues consist of spleen, lymph nodes, tonsils,
and Peyer's patches. All type of blood cells originate from a pluripotent stem cell found
in the yolk sac and fetal liver during fetal development and in the bone marrow, thymus,
and spleen of the adult (49, 50) . In most mammals. bone marrow is the major source of
red cells, platelets, and granulocytes as well as lymphocytes and monocytes. The
pluripotent stem cell differentiates into another type of cell called the progenitor cell.
One type of progenitor cells passes through the thymus, becomes mature and develops
into the thymus-derived T-lymphocyte (T-cell) . (51) Mature T lymphocytes are found
in the thymic dependent areas of spleen and lymph nodes and comprise about 55-74% of
total peripheral blood lymphocytes. The bursa of fabricius (birds) or bone marrow
(other species) processes a different type of progenitor cell which mature into the
mature B-lymphocyte (B-cell). Mature B lymphocytes are found in the B-cell
dependent areas of spleen and lymph nodes and represent approximately 25-40% of
peripheral blood lymphocytes (51). Following activation B lymphocytes proliferate and
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differentiate into antibody-producing cells and plasma cells . T and B cells can be
distinguished by their cell surface markers (52) .
When foreign substances ( viruses, bacteria, foreign cells, etc.) i. e. antig ens,
come into the body, they bind to the antigen-presenting cell (macrophage) first. This
antigen-presenting cell stimulates the T-lymphocyte to become activated and divide to
expand the number of T-helper cells (TH). These T-helper cells
responses,

delayed -type

activate antibody

hypersensitivity (TDTH). suppressor T-cell (Ts). and

cytotoxic T-cell. Cytoto xic T cells participate directly as killer cells against virally
infected host cells, malignant cells , and foreign tissues.
The mediators of various immune responses are soluble factors, now common ly
known as lymphokines, produced by one or another type of cell of the immune system.
Following binding of the T-cell to the antigen -presenting cell , an unknown factor from
the T·cell is produced. This soluble factor subsequently induces the antigen-presenting
cell to produce a small protein with a molecular weight of approximately 15,000
daltons called interleukin-1

also known as lymphocyte activating factor (LAF ).

lnterleukin-1 stimulates the T-cell to release interleukin-2 which drives antigen
activated cells into proliferation . In mice, interleukin-2 has a molecular weight of
20,000-30,000 daltons. lnterleukin-2 production requires two signals ; exposure to
mitogen (such as ConA or PHA), or antigen presented on the surface of macrophage and
exposure to interleukin-1. lnterleukin -2, formerly known as the T -cell growth factor
(TCGF) is a strong mitogen for both the T-helper cell and the T-cytotoxic cell, providing
these cells have had prior exposure to an antigen. The antigen also can bind to the B·
lymphocyte and stimulates one or more specific B cells to clone and produce specific
antibody.
In summary , immunity is mediated by

B lymphocytes that are responsible for

humoral immunity, T lymphocytes that are responsible for cell-mediated immunity, and
macrophages that are involved in antigen recognition and phagocytosis. The cytotoxic T·
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ce ll participates directly as a killer cell against viral infected cells, foreign tissues ,
etc .. Macrophages also play a central role in cell-mediated immunity . They are involved
in the initiation of responses as antigen-presenting cells, in regulatory functions , and
participate as effector cells in inflammatory and tumor cells.
Assessing T and B Cell Function
Antigen -induced lymphocyte proliferation can be detected in Y.iJ.LQ. by cultivating
lymphoid cells with specific mitogens. Mitog ens are defined as lectin proteins derived
gene rally from leguminous plants and bacteria. After binding to the cell surface
dete rminants , mitogens polyclonally stimulate lymphocytes into a lymphoblast through
DNA synthesis, blast transformation , and result in division of lymphocyt es. Mitogen
stimulation of lymphocytes ilL Y.iJ.LQ. is believed to reflect the ability of lymphocytes to
respond to a foreign

antig~Jn

in

~-

T and B cells are activated by different mitogens (53) which can be used as a
gross probe for the integrity of T-cell and B-cell function (54) . Phytohemagglutinin
(PHA), derived from the red kidney bean Phaseolus vulgaris, primarily stimulates both
human and mouse T-helper cells and has some effect on T-cytotoxic and T-suppressor
cells. Concanavalin A (ConA), a lectin derived from the jack bean, Canavalia ensiformis,
stimulates both murine and human T-helper cells, T-suppressor and T-cytotoxic cells.
Pokeweed mitogen (PWM), a lectin derived from pokeweed plant, Phytolacca americana,
stimulates both human T and B cells. Lipopolysaccharide (LPS), known as endotoxin A. is
a protein derived from a variety of gram negative bacteria which stimulates mouse B
cells but not human B cells.
T cells carry out functions of immune regulation by participating as amplifying
'helper" cells in antibody response, mixed lymphocyte reaction, delayed-type
1ypersensitivity, and activation of cytotoxic T cells (48). The essence of the immune

I3
response is to activate a small number of precursor cells and expand th em into a
population of functional effector cells. Lymphocyte proliferation is strongly correlated
with DNA replication , protein synthesis, and production of antibodies, lymphokines. and
enzymes. Some chemicals can inhibit these macromolecular synthesis. Inhibitors of
protein synthesis are also known as immunosuppresants (55).
Since mitosis involves the production of new DNA, the amount of proliferation
can be quantitated by .neasuring the amount of DNA synthesis (56). Measuring DNA
synthesis can also determine the ability of lymphocytes to respond to a foreign antigen
oy cell division and differentiation into blast cells .
Natural Kmer INKl

Cells

Some lymphocytes having neither B nor T cell surface markers are called "null
cells". These cells, active in immune cytotoxic functions, are the NK cells, and killer
cells, the later mediating the antibody-dependent-cell-mediated -cy totoxicity (ADCC )
157) . The mechanisms of natural killing are yet unknown. Howeve r, it has be en
suggested that there are three distinct phases directly binding to the target cells, a Ca++
dependent phase, involving vesicular secretion that modifies the target cells so that it is
'programmed" for lysis (58), and a tate phase during which the "programmed" cell
undergoes lysis.
The NK cells are cytotoxic against a broad spectrum of target cells

irL ¥i.trQ and

Exercise this function without prior immunization (59). The spontaneous natural
cytotoxicity of the NK cells is an important mechanism in resistance to tumor and viral
ciseases. NK cells appear to be one of the first-tine defenses against viral or chemical
tansformed cells. NK cells are active in tumor surveillance (60) and can control viral
i ~ fections (61 ). The NK cell constitutes about 5% of the peripheral blood lymphocytes

and splenic lymphocytes in man and other animals. Generally, NK cells can lyse both
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allogenic and syngeneic tumor cells (62, 63) and have no requirement for MHC
restriction . The NK activity is greatly enhanced by interferon or by anything that can
induce interferon production such as chemical, and virus infection.
In Yitro Assessment of NK Cell Activjty

NK activity ca .~ be assayed based on the diffusion of radioactive chromate
(51 Cr204 -2) ion through the cell membrane (64). The susceptible tumor cells are
first labeled with radioactive chromium and then incubated with NK cells. Thus, 5 1Cr is
released from a labeled target cell into the supernatant fluid because the cell membrane
is damaged to allow the efflux of intracellular molecules. Killing activity is measured by
the amount of 51 Cr released from lysed cells . The 51 Cr release assay represents a
simple, rapid, and quantitative test for cell -mediated cytolysis .
Possjble Mechanjsms of lmmpne Toxicity

Due to the complexity of the immune system, only a limited number of studies
have investigated interaction between chemicals and immune functions . In many cases,
the active sites of immunotoxicity are not well understood because the chem ical
interactions are difficult to investigate (4). Exposure to a chemical may cause a variety
of reactions by enhancing or suppressing host immune response or it may have no effect
on the Immune system at doses that induce toxicity in other organs (4) . So it is
important In any toxicological study to consider the immune system as a whole (65). The
immune system of mice is understood very well and is often used in immunology and
toxicology. The use of an animal model provides useful information about the role of
chemicals in altering immune function . The animal model can also be compared with
results of human data and allow better understanding of the basic immunotoxicity in
alteration of the immune functions by methylene chloride.
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It is now well known that toxicity of chemicals is due to the formation of reactive
intermediates during the: metabolism (7) . These intermediates might cause some serious
toxicities. The roles of toxins on various types of toxicity are (53) alteration of
biological factors (such as ions and cofactors), enzymes, hormones, and pharmacological
receptors that will cause the acute or chronic toxicity symptoms, such as
hypersensitivity,

neurotoxicity

(66) , and

blood

disorders

(67);

the

reactive

intermediates with body macromolecules might cause necrosis followed by cell death
(68); chemicals or their metabolites with genetic material might lead to genetic
alterations such as mutagenesis and carcinogenesis (14, 15) and many carcinogens are
also immunosuppressive (69).
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CHAPTER Ill
MATERIALS AND METHODS
Experjmenta! Qesjgo

The present study investigated the effects of methylene chloride on the function of
immune cells, in particular cell-mediated immunity. The experiments were performed
on spleen cells of mice (CD·1 strain) following both
methylene chloride.

in~

and in rilm treatment with

Also studied were the peripheral blood mononuclear cells from

healthy male volunteers following in :.1trQ. exposure to methylene chloride. The immune
parameters analyzed were T cell blastogenic responses to mitogen (PHA) , IL-2
production , and NK cell activity against the tumor cell line K562.
Procedme of Assay Methods

Experimental animals. Young adult male mice of inbred strain CD·1 (Charles
River Laboratory, CA) were obtained at 4·6 weeks old, and acclimatized for 2 days
prior to experimentation.
each with

The mice were randomly assigned to 4 experimental groups,

5 mice per treatment. The mice were fed a routine lab diet and water ad

libitum.
Dosage levels and mode of administration. The solvent control and solvent for
methylene chloride was corn oil. All dosing solutions were administered at volume of 0.1
ml/10 g body weight (1 0 ml/kg). Methylene chloride was administered by gavage to
groups of mice at dose levels of 0. 100, 500, and 2,500 mg/kg. Control mice were fed
the corn oil (10 mllkg) only (43). The mice were killed with

C02 anesthesia at 15,

23, and 30 days after exposure. At the time of sacrifice, animals and the major organs
(e. g., liver, thymus, spleen , and kidney) were weighed and spleens were studied for
immune function described below.
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Splenic mononuciJar cells. Spleens were put into a petri dish immediately afler

the mice were killed and 15 ml of mouse RPMI -1640 were added. The RPMI-1640 was
s upplemented with 1% sodium pyruvate, 1% 2-mercaptoethanol, 100 units/ ml
penicillin , and 100 P. g/ml streptomycin (medium) . Spleens were minced and a stainless
wire mesh screen was placed over them. A plastic barrel from the syringe was used to
force the cells

through the screen and the cells were transferred to 15 ml centriluge

tubes (25310, Corning Glass Ware , Corning, NY) . The dissociated spleen cells were
washed twice with 10 ml medium at 200 x g for 5 min. After a second wash , 9 ml of
double dislilled water was added to the cell pellet to lyse the red blood cells . After 10-15
seconds of mixing, 1 ml 0f 10 times concentrated PBS was added to the tube to stop the
reaction . The cell debris was removed by centrifuging at 200 x g for 5 min and the
dissociated spleen cells were resuspended in 5-10 ml medium .
Separation of

freshly drawn blood

peripheral blood mononuclear cells. Thirty -five to fifty ml ol

from healthy male volunteers were drawn into syringes which

contained 10 units of preservative-free heparin (Sigma Chemical Co., St. Louis, MO),
for every 10 ml blood. Plasma was removed by centrifugation (CU 5000; Damon/IEC
Division, Needham Hts., MA) at 500 x g for 15 min and about 7 ml of the remaining
cells were layered over 3 ml of Fico II Histopaque-1 077 gradient (Sigma) in 15 ml
plastic conical tubes (Corning), and centrifuged at 400 x g for 20 min. The PBMC,
obtained from the gradient interface, were suspended in RPMI-1640 medium (GIBCO
Laboratories, Grand Is! and, NY) that was supplemented with 100 units penicillin and
100).1 g streptomycin (GIBCO) per ml of medium, and centrifuged at 300 x g for 10 min.
The supernatant was decanted and the PBMC were resuspended

in medium and

centrifuged at 200 x g for 5 min. After the supernatant was decanted, the cells were
adjusted to a concentration of 5xto6 in RPMI-1640 medium .
Exposure to methylene chloride (for both human and mouse in vitro studies).

PBMC or murine splenic cells were incubated with different concentrations of methylene
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chloride (EM industries Inc. , Gibbstown , NJ), which were dissolved in 1% dimethyl
sulfoxide (DMSO) and diluted in RPMI-1640. Due to its

high volatility, methylene

chloride preparations were stored at 4oc. The PBMC cells were incubated in 24-well
flat-bottomed culture plates

for 3, 5, and 7, days following exposure to various

concentrations of methylene chloride including: 0 (control), 1o-2 , 10-3, 1o-4 , and
1o- 5 M. The splenic cells were incubated with methylene chloride for 6 hours in sealed
tubes or plates.
Viability of cells. The number (%) of viable lymphocytes were

examined by

staining the cells with trypan blue (0 .2%) . Viable cells excluded the dye while dead cells
took up the dye. The percentage of viable cells

=

(numbe r of viable cells I number of

viable cells + number of dead cells ) x 100%
Lymphocyte blastogenesis assay. This assay was carried out as described by

Oppenheim and Schecter (70). Cultures, 1 x 1o6 PBMC/ml, were established in
triplicate

in

96-well

flat

bottom

microculture

plates

(25860,

Corning)

and

phytohemagglutinin (PHA) (GIBCO), 1, 0.5, and 0.25% of stock solution was added
giving a total volume of 0.2 ml per well.

PBMC incubated in RPMI-1640 containing

20% fetal calf serum (FCS) (Hyclone, Logan , UT) without PHA were used for control
cultures which received the same volume and cell numbers as the wells containing PHA.
The cultures were incubated for 3 days at 37oc in a humidified atmosphere of 5% C02 in
air. Twelve hours before harvesting, 0.5 1-L Ci of Methyi-[3H]thymidine (New England
Nuclear, Boston, MA). having a specific activity of 2 Ci/mmol, was added to each well. At
the end of the culture period, cells were harvested onto glass fiber filters (Skatron Inc. ,
Sterling, VA) with an semi-automated Titertek harvester (FLOW Laboratories,
lnglewook, CA) . The filters were dried at 60°C for at least 30 minutes and the filter
discs which contained the cells were removed and placed into plastic counting vials
(Skatron). To each vial was added 2 ml of scintillation fluid

SCINTIVERSE (Fisher

Scientific, Fair Lawn, NJ). Radioactivity of samples was determined in a scintillation
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spectrometer (Parkard Tri Carb. 1500; Packard Instruments, Downers Grove, IL) . The
murine lymphocyte responses to the mitogen PHA was assayed by culturing 5 x 105
splenic cells with various concentrations of PHA in flat bottom 96 well tissue culture
plates. Twenty-four hours before harvest, tritiated-thymidine was added to the cultures
and cells were harvested and radioactivity determined as in the human blastogenesis
assay.
Lymphocyte IL-2 production assay. The IL-2 production assay was carried out
as described by Gills et al. (71 ). The interleukin-2 dependent HT-2 cell line was
maintained in medium made up of 60% by volume RPMI-1640 supplemented with 2%
FCS , penicillin and streptomycin (GIBCO) and 40% supernatant from rat spleen cells as
the source of IL-2 prepared in advance by the stimulation of splenic cells in cultures
(which were incubated in RPMI-1640 containing Con A at a concentration of 1 A g/ml).
Methylene chloride-treated lymphocytes were obtained as described before and incubated
In 4 ml culture tubes (American Scientific Products) at a concentration of 2 x 106/ml
in 2 ml of RPMI-1640 containing 1% PHA, 5% FCS, 1% 2-mercaptoethanol and sodium
pyruvate for 48 hr in humidified atmosphere of 5% co 2 in air at 37oc . The controls
were incubated with same cell numbers and medium without PHA. After 48 hr, the cells
were centrifuged at 400 x g for 10 min. The supernatant was saved to test for the
biological activity of IL-2.
IL-2 activity was determined in a bioassay based on the IL-2 dependent HT-2
cell proliferation. HT-2 c.3lls were washed and resuspended at a concentration of 4 x
1 0 4tml in RPMI-1640 containing 2% FCS, penicillin, streptomycin , and 1% 2mercaptoethanol. Each time an unknown sample was assayed, a reference standard of 50
units of human recombinant IL-2 (Genzyme, Boston, MA) in serial two-fold dilutions
was used as a positive control. The testing of culture supernatants were carried out in
two-fold serial dilutions in RPMI-1640 and prepared in triplicate wells (0.1 ml/well)
of a 96-well flat-bottomed microplate (25860, Corning). A volume of 0.1 ml of the
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HT -2 cell suspension was added to each well and the cells were incubated at 37oc in a
humidified atmosphere of 5% C02 in air for 24 hr. After this incubation period, 0.4
1!. Ci 3H -thymidine (New England Nuclear) was added to each well and cultured for an
additional 4 h. The cells were harvested and determined as in lymphocyte blastogenesis
assay described before.
NK cell assay (for human study only). The details of the chromium release for
determining natural cell killing activity have been described by Warren et al . (72 ).
Human leukemia K-562 cells (ATCC , Rockville , MD) were cultured in RPMI -1640
containing 10% FCS at 37°C , 5% C02. The cells were centrifuged at 200 x g for 5 min
and incubated at 37°C with 0.1 ml of 51cr (sodium chromate, ca. 2 mCi/mmole ) for at
least 1 h. Methylene chloride treated PBMC (effector cells) were washed one time in
RPMI-1640 and resuspended at a concentration of 5 x 106/ml in medium supplemented
with 20% FCS . A volume of 0.1 ml of PBMC was placed in triplicate wells of a 96 -well
round-bottomed microplate (25850 , Corning) for a 50:1 effector to target cell ratio. In
addition , two-fold dilutions of the PBMC were carried out in 20% FCS, giving effector to
target cell ratios of 25:1, 12:1 and 6:1. Target cells were incubated in medium with
20% FCS for determination of spontaneous release and maximal release was determined
by incubated target cells in 0.5% saponin (Sigma).
After 1 h of incubation, the 51 Cr-labeled target cells were washed 3 times in
cold medium and resuspended at a concentration of 1 x 105/ml in medium . One-tenth ml
of the target ceH suspension was added to each well and the plates were incubated for 4 h
at 37°C in 5% C02. Aliquots of 0.1 ml were pipetted from each well into 5 ml plastic
vials (American Scientific Products, McGaw Park, IL) and radioactivity was determined
with

a

Packard

Model

3320

Tri-Carb

Scintillation

Spectrometer

( Packard

Instruments) . Percent 51 Cr release was calculated by the following formula:
Experimental release - Spontaneous release

% release

X

Maximal release - Spontaneous release

100
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Statistical analysis. Data were pooled from triplicate samples and analyzed using

Student's t-test and the least significant difference test with a 95% confidence interval
for a normal distribution . The observed relative enhancement or suppression of activ ity
for the human natural killer cell assay, blastogenesis assay and IL-2 production are
presented

in graphic form . Error bars on graphs are representative of the standard

error of the mean (SEM).
Results from the assay for I L-2

were derived using a human recombinant

interleukin -2 standard curve . This was done by plotting known recombinant IL-2
activity (units/ml) against counts per minute of [3H]-thymidine. The values of the
unknown samples were extrapolated from the standard curve of recombinant IL-2, to
obtain the concentration of IL-2 activity in the unknown samples. One unit was defined
as half the amount of IL-2 activity that would stimulate 50% of maximal total
incorporation. The results were then analyzed using the t-test mentioned above.
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CHAPTER IV
RESULTS
Murjne In Vivo Studjes

Body and specific organ mass. Toxicological manifestations in the immune system
following xenobiotic exposure in experimental animals may

appear as changes in

lymphoid organ mass. Therefore , it is essential in immunotoxicity evaluation to weigh
the thymus and spleen (1 ). In general. the animals gained or maintained their mass
during the experiments. The body mass of mice exposed to various levels of methylene
chloride are given in Table I.
chloride and corn oil (solvent)

No significant difference between mice given methyl ene
alone was seen with the

exception of mice receiving

2,500 mg/kg methylene chloride for 15 days. Specific organ mass on the basis of gig
body mass for thymus and spleen were variable and no significant differences were found
between corn oil and methylene chloride treated mice (Table II). The mass of liver was
not significantly different between mice given methylene chloride as compared to mice
given corn oil only (Table II). In general, no changes in the appearance of these organ s
were seen in methylene chloride treated mice.
Lymphocyte blastogenesis responses. Responses of spleen cells to several
co ncentrations of the T-cell mitogen PHA, following

in yjyQ_ administration of 100,

500, and 2,500,u M of methylene chloride for 15, 23, and 30 days are shown in figure
t, 2, and 3, respectively.

The methlene-chloride treated mice had statistically

significant (p < 0.05) lower blastogenic activity than the corn oil-treated group
/L-2 production activity. In figure 4 is shown the human recombinant IL-2
>tandard curve that was represented by plotting counts per minute (CPM) against IL-2
1ctivity (units/ml). Splenic cells of methylene chloride treated mice exhibited a
jecreased level of IL-2 production as compared to control mice. This alteration in IL-2
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TABLE I
Animal mass (g) after methylene chloride exposure

Treatment a

Diluent

1 00

500

2500

Day o b

20 .3
o.8c

20.7
1.1

21 .0
1 .0

20 .0
1 .0

Day

23 .0
2 .5

23 .5
1 .0

23 .2
1.0

21 . 1
1 .1

Day 15

26.3
1.3

25 .8
1 .7

24.8
1.0

23 .0.
1.4

Day 23

27 .0
1.0

26 .5
1.9

26 .3
0.6

24 . 8
2 .6

Day 30

28 .2
0.7

27 .4
1.5

2 7. 1
0 .7

26 .0
1.1

8

a. Animals were administered by gavage daily with corn oil (diluent) or methylene

chloride at doses of 100, 500, or 2,500 mg/kg for 30 days.

b. Mean mass at the beginning of each week and at the time of sacrifice . N=5 for
each group.

c. Standard deviation of the mean.
• Significantly decreased {p < 0.05) .
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TABLE II

Specific organ mass (g) after methylene chloride exposure

---------------------------------------------------------Treatmenta :
Diluent
100
500
2500
Mice per Treatment

6

7

7

7

Thymus mass b

2 .33
0.58 c

3 .54
0 .37

3.36
0 . 81

3.14
0 .96

Liver mass d

68 .0
7.5

69 .2
6.1

72.4
7.3

73 .0
49

Spleen masse

6 .2 9
1 .03

5 . 86
0 . 84

6.21
0 .59

5.84
0.61

Kidney mass f

27 .8
9.6

27.1
5.9

24.1
6.5

23.7
10 .3

a. Mice were administered by gavage daily with diluent (corn oil) alone or methylen e
chloride at doses of 100, 500, 2,500 mg/kg for 30 days . Parameters were studied at
time of sacrifice.
b. Mean thymus mass in units of g/1 OOOg body mass.
c. Standard deviation of the mean.
d. Mean spleen mass in units of g/1OOOg body mass.
e. Mean liver mass in units of g/1 OOOg body mass.

f. Mean kidney mass in units of g/1OOOg body mass.

25

15-days of treatment
15

II
•

IZI

en

"'C

D

10

Control
100 mg/kg
500 mg/kg
2,500 mg/kg

c:
en

Ill

::I
0

£
.5
::::e
0..

(.)

5

0
1%

Figure I .

thymid ine

uptake

0.25%
0.5%
PHA, %of stock solution

Effect of mice
in

.in ~ exposure to methylene chloride on [3 H J

lymphocytes

st imulated with

various

co nce ntrat ions

of

phytohemagglutinin (PHA) . Values are expressed as mean incorpor ation of counts per
minute of tritiated thym idine and standard error of the mean . PHA responses of CD -1
mice splenic cells treated with various concentrations of meth ylene chl oride for 15
days. A significantly decreased mitogenic activity was found at each PHA concent ration (p
< 0.05) . N=5 .
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Figure 4. Human recombinant IL-2 standard curve. The proliferative response of
HT·2 cells was used to analyze the unknown samples by comparing them with the IL-2
standard curve . Counts per minute (CPM) was plotted against IL-2 activity which was
represented as units/mi.

Human recombinant IL-2 (50 units/ml) was studied in serial

two fold dilutions. To each well was added 0.1 ml of HT-2 cells at 4 x 104/ ml in
medium.The plate was incubated for 24 hours and during last four hours the cells were
pulsed with tritiated thymidine and the incorporation of counts per minute of [3Hj thymidine were counted with a liquid scintillation counter.
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significant (p < 0.05) for mice receiving 100, 500, and 2,500

.),1

M methylene chloride

for 15, 23, and 30 days. The results are shown in figure 5.
Mprine In Vitro Studjes

Lymphocyte blastogenesis response. Responses of splenic cells to several
concentrations of the T cell mitogen PHA are shown in figures 6. No significant
differences were seen between responses of splenic cells that were incubated in RPMI1640 (diluent) and of those that were treated with methylene chloride for 6 hours.
IL -2 production activity. In figure 7 is the effect of

in. Y.i.J..[Q_exposure to

methylene chloride on IL-2 production of murine splenic cells . Splenic cells were
incubat ed with various concentrations of methylene chloride for 6 hours. Values were
expressed as IL-2 activity (units/ml). No significant differences were se en between
responses of splenic cells that were treated with methylene chloride and those that were
treated with RPMI-1640 (diluent).

Human In Vitro Stpdjes

Lymphocyte blastogenesis response. Responses of PBMC to several concentration s
to the T cell mitogen PHA are shown in figures 8, 9 and 10 respectively. No significant
differences were seen between responses of PBMC that were incubated in RPMI and of
those that were treated with methylene chloride for 3, 5, and 7 days.
NK cell activity. In figure 11, 12 and 13 are the results of ths NK assay
comparing PBMC of control group and PBMC treated with various concentrations of
methylene chloride. Although there seems to be a trend of higher NK activity by cells
from treated PBMC, the small difference in mean 51 Cr-released at four effector to
target cell ratios was not significant.
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Effect of

, 23 days ( -+-
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activity . Values

are

in.. l!.i.YQ exposure to methylene chloride tor 15 days
). and 30 days ( -a- ) on murine interleukin-2 production

expressed as IL-2a activity (units/ml). A significantly (p <

0.05) decreased IL-2 production activity was found at each concentration of methyl ene
chlo ride.
a. IL-2 activity which represented as uni ts/ml was derived from IL-2 standard

curve (Fig. 4) .
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Figure 6. Splenic cells were isolated from male mice and treated with various

concentrations of methylene chloride
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~

for 6 hours and assessed for blastogenic

response to PHA. Blastogenic response is expressed as mean incorporation in counts per
minute of tritiated thymidine and standard error of the mean . No sig nificant differences
were found between control splenic cells and splenic cells treated with ta·3, 1o-4, and
1o-5 M of methylene chloride. N=S.
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Values were expressed as IL-2 activity (units/ml).

No significant

difference was found between control splenic cells and cells treated with 1o-3 , 1o-4 ,
and 1o-5 M of methylent chloride . N=5.
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differences were found between response of control PBMC and of PBMC treated with
1o-3 , 10 -4 , and 1o-5 M of methylene chloride for 3 days. N= 7.
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Figure 9. Mean incorporation in counts per minute of tritiated thymidine and
standard error of the mean of peripheral blood mononuclear cells. No significant
differences were found between response of control PBMC and of PBMC treated with
1o-3, 1o-4, and 1o-5 M of methylene chloride for 5 days. N~ 7.

35

7-days of treatment

80

•
•

E:J

IJ)

0

60

Control
1,000)JM
100)JM
10)..1M

"0

c:

"'

IJ)

::J
0

=

40

-::;,:=
0..

(.)

20

0
1%

0.5%
PHA , %of stock solution

0 .25%

Figure 10. Mean incorporation in counts per minute of tritiated thymidine and

standard error of the mean of peripheral blood mononuclear cel ls . No significant
differences were found between response of con trol PBMC and of PBMC treated with
1o-3, 10-4. and 10-S M of methylene chloride for 7 days. N=7.

36

3-days of treatment

50

F1J

Control

•

1 ,000)-(M
100)..(M
10)-(M

40

cv
en
ca
cv

~

E:;]

0

30

u...

ll')

~

20

c

ra

cv

:E
10

0
50:1

25 : 1

12:1

6:1

Effector to target cell ratio

Fl igure 11.

Natural killer cell activity represented as mean percent 51 C r

release and standard error of the mean at various ratios of effector to larget cells. No
significant differences were found between results obtained using PBMC incubated in
medium and PBMC treated with va rious concentration of methylene chloride for 3
days. N=7.
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Figure 12. Natural killer cell activity represented as mean percent 51 C r
release and sta ndard error of the mean at various rat ios of effector to targe t cells. No
significan t differences were found be tween results obtained using PB MC incubated in
medium and PBMC treated with various conce ntration of methy lene chlo ride for 5
days. N=7.
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significant diffe rences were found betwE>en results obtain ed using PBMC incubated in
medium and PBMC treated with various r:oncentration of methylene chloride for 7 days.

39
/L -2 production activity. In figure 14 are data suggesting slightly increa sed
human IL-2 production following

in~

exposure of PBMC to various concentrations

of melhylene chloride . Although there seems to be a trend of higher IL-2 production
activity by cells from treated PBMC, the small difference is not significant.
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Figure 14. Effect of

.in

\d.1rQ. exposure to methylene chloride on IL-2

production of human PBMC. PBMC were incubated with 0, 1Q·3, 1o-4, and 10·5 M
methylene chloride and assessed for IL-2 production following 3 days ( -o( -+-

). and

),

5 days

7 days ( -o- ) of this treatmenl. Values are expressed as IL-2 activity

(units/ml) and standard error of the mean. No significant differences were found
between response of control PBMC and of PBMC treated with 10·3, 10·4 and 10·5 M of
methylene chloride. N= 7.

41
CHAPTERV
DISCUSSION
Many toxicities have been associated with methylene chloride exposure (see
literature review in Cha pter II) . For example, this exposure may cause various
neurochemical changes in th e cerebral cortex and hypertrophy or proliferatio n of
astroglia l cells. Howeve r, only a very limited number of studies have been conducted on
immunotoxicites associated with this chemical. Exposure to bromoform

may suppress

phagocytosis function (18), exposure to chloroform has bee n reported to decrease Tdependent antibody respo nse anti-SRBC in both male and fem ale mice (18), and
expos ure to bromodichloromethane has been found to depress delayed-type
hypersensitivity (19).
A murine model was used in the prese nt study in attempt to obtain additional
information on the

i.o.~

effects of methylene chloride on the immun e system. A murine

model has been used successfully in studies of immunotoxicities associated with many
chem icals (17, 18, 19). The present studies investigated effects of th e administ ration of
methylene chloride on murine body and specific organ mass and blastoge nic activity and
IL-2 production of murine splenic cells.
The ability of T lymphocytes to proliferate in response to antigen and mitogen is
thought to reflect

in_~

functional capability . PHA binds to both B and T lymp hocytes,

but stimulates blast transformation only in T cells. Thus, reduced proliferative response
to

PHA of splenic cells from mice treated with methylene chloride indicates that this

chemical alters T cell function.

However, it is not clear whether it is methylen e

chloride or its active intermediates which suppresses lymphocyte blastogenic activity.
The metabolism of methylene chloride which involves alkylation of DNA by a reactive
metabolite and incorporation into the normal
been studied both

pathways of DNA biosyn thesis (73) has

in human subjects and in animals.

Format ion of reac tive

intermediates may alter or inhibit the synth esis of various prot eins which are
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important for lymphocyte DNA replication. Through these possible mechanisms,
methylene or its metabolites may interfere with normal lymphocyte DNA synthesis and
cause lower proliferation response.
Much evidence indicates that IL·2, one of the most studied lymphokines, is
produced by the helper T cells and plays an important role in the generation of cytotoxic
T cells. IL-2 also enhances helper T-cell activities that promote B-cell function and
stimulates NK cell activity . Another important role for IL-2 in the modulation of
immune function is to act on another set of T lymphocytes to produce gamma·interferon
(73), another lymphokine regulating a variety of host functions, including antiviral and
' 11unoregulatory responses (74) and NK·cell cytotoxicity (75). The current findings
show that exposure to methylene chloride

i.a :ill!.Q. has a suppressive effect on both T-cell

blastogenic activity and IL-2 production. It is well known that IL-2 is a strong mitogen
for both cytotoxic T and helper T cells. Lotze and Rosenberg (73) have reported that
mitogen-stimulated T·cell proliferation depends on the production of IL·2. Therefore ,
the lower T·cell blastogenic activity from methylene chloride treated mice is possibly
due to defective IL·2 production .
Another possibility for the inhibitory effect of methylene chloride might be

an

indirect effect on endocrine and/or the CNS. Since endocrine mechanisms influence the
immune system (76), and the CNS is also involved in the modulation of immune
responses (77). It is possible that a chemical affecting one of these two systems may
have an indirect effect on the suppression of immune functions.
investigation were also carried out to determine if exposure of murine splenic
cells or human PBMC to methylene chloride in tissue culture altered certain of their
immune parameters

i.a ....rilrQ. The present study assessed blastogenic activity , IL·2

production , and NK cell activity of murine splenic cells and PBMC following

i.a yjUQ

inc ubation with methylene chloride . The findings indicated that exposure of mouse

43
splenic C'9lls to methylene chloride in tissue culture did not have a suppressive effect on
the bla stogenic activity c:nd IL-2 production activity_
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CHAPTER VI

CCX\CLLJSia'.IS
A number of toxicities have been associated with exposure to methylene chloride
including renal necrosis, pulmonary injury, CNS damage, and hepatotoxicity. In order to
examine the basis of possible immunotoxicities associated with methylene chloride
exposure, several tests of cellular immune function were performed using a murine
model and PBMC from healthy human subjects.
In the murine model, methylene chloride , even when given at high doses, was
tolerated relatively well. Body mass, specific organ mass for thymus, kidney, spleen.
and liver

were found to be normal. However, CD-1 mice given methylene chloride

demonstrated a significantly decreased blastogenic response to PHA and depressed IL-2
production .

Decreased mitogenic response reflects

depressed T cell function and is

associated with reduced IL-2 production . Although the exact mechanism of methylene
chloride induced suppression of immune function is not known, it has been suggested that
this chemical and/or its intermediates may cause toxicities by altering several cellular
functions, such as cell membrane, enzymes, hormones, and binding receptors. Methylene
chloride

also can prevent or modify the synthesis of various proteins, antibodies and

various enzymes which are important for the immune functions . Indirectly, methylene
chloride may affect the endocrine system and/or the CNS which in turn may produce
substances which effect the immune system. That products of the endocrine system and
CNS have influence on the immune system is thoroughly established. On the contrary,
upon exposure of murine splenic cells to methylene chloride

iiJ.ll.iJLQ. no significant

depression of T cell blastogenic response and IL-2 production activity was found.
Immune function of PBMC from healthy human subjects was investigated at 3, 5.
and 7 days after

ill 'li1[Q exposure to various concentrations of methylene chloride. No

significant depression was found in NK cell
mitogen PHA or IL-2 production.

activity, blastogenic response to the T -cell
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The present study showed depression of imm une funct ion s follow ing

illl!.iJLQ

expos ure to methylene chloride but no decrease in selected immune parameters were
observed following

ill ritr·;Lexposure to this chemical both in human PBMC and murine

splenic cells. But this difference in findings were anticipated since there are limitations
associa ted with

ill W£Q

ill :t.i.trQ.

test systems . First, metabolic alteration of methylene chloride

may not be the same as it is

ill .IdYlL. since methylene chloride metabolism

require s microsomal cytochrome P-450 monooxygenase which is like ly to be either
abse nt or in trace amounts in lymphoid cell suspension. Secondly, as mentioned above,
methylene chloride may be having an indirect effect on the immune system through some
othe r sys tem such as the endocrine system or the CNS which could not be detected

Yilr..Q..

ill
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